Solriamfetol Improves Excessive Daytime Sleepiness in Obstructive Sleep Apnea
Solriamfetol, a dopamine-norepinephrine reuptake inhibitor, improves excessive daytime sleepiness in OSA regardless of primary OSA therapy adherence.
Obstructive Sleep Apnea
Untreated Obstructive Sleep Apnea Linked to More Influenza Hospitalizations
There may be increased hospitalization risk from influenza infection in patients with obstructive sleep apnea who do not use continuous positive airway pressure.
Treatment Improves Chronic Pain Outcomes Associated With Poor Sleep
A systematic scoping review examines the literature about the influence of sleep disorders and disturbance on pain outcomes among US veterans with chronic nonmalignant pain.
Novel Rx Device for Sleep Apnea, Snoring Gets FDA Approval
The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue.
Obstructive Sleep Apnea During the COVID-19 Pandemic: Increased Mortality Risk and Viral Spread
Researchers reviewed COVID-19 literature to determine the relationship between obstructive sleep apnea (OSA) and adverse COVID-19 outcomes.
Solriamfetol Improves Driving Performance in Patients With Excessive Daytime Sleepiness and Obstructive Sleep Apnea
Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
Snoring Predicts Risk of Cerebral Events in Patients With OSA and CVD
Snoring is associated with increased risk of cerebral events in patients with obstructive sleep apnea and established cardiovascular disease.
Acetazolamide May Improve AHI in Obstructive and Central Sleep Apnea
Patients with obstructive or central sleep apnea experienced improvements in apnea-hypopnea index following treatment with acetazolamide.
Obstructive Sleep Apnea Burden Improvement With vs Without Upper Airway Stimulation
The burden of both objective and subjective obstructive sleep apnea improved more in patients who received upper airway stimulation compared with those who did not.
Improvement of Sleep Apnea and Sleep Patterns May Improve Glycemic Control in Black Patients
Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
-
Loading...
-
Loading...
Next post in Sleep Information Center
